Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients

Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients

Introduction In the general population, hyperuricemia is associated with increased morbidity and mortality. Data on this association in hemodialysis patients is controversial. Moreover, it remains elusive whether serum uric acid (SUA) lowering therapy is associated with mortality. Methods Retrospect...

Full description

Bibliographic Details
Main Authors: Benjamin Rohn, Wiebke Jansing, Felix S. Seibert, Thiemo Pfab, Okan Cinkilic, Jürgen Paßfall, Sven Schmidt, Nina Babel, Frederic Bauer, Timm H. Westhoff
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Renal Failure
Subjects:
chronic kidney disease
hyperuricemia
hemodialysis
mortality
gout
Online Access:http://dx.doi.org/10.1080/0886022X.2020.1835674

Internet

http://dx.doi.org/10.1080/0886022X.2020.1835674

Similar Items